Skip to main content

Table 1 Demographic and clinical data of studied AF patients categorized according to the outcome of CA

From: Pre-procedural high serum visfatin and tumor necrosis factor-α might predict recurrent atrial fibrillation after catheter ablation

Variables

RAF (n = 41)

No RAF (n = 76)

Significance of difference

Type of AF

   

 Persistent (n = 26)

12 (46.2%)

14 (63.8%)

0.178

 Paroxysmal (n = 91)

29 (31.9%)

62 (68.1%)

 

Age (years)

68.3 ± 7.2

63.8 ± 10.1

0.014

Sex

   

 Males

33 (80.5%)

57 (75%)

0.501

 Females

8 (19.5%)

19 (25%)

 

Body mass index (kg/m2)

31.8 ± 3.1

30.3 ± 3.3

0.0223

Associated medical disorders

   

 Number

   

  No

7 (17%)

16 (21.1%)

0.759

  One

25 (61%)

47 (61.8%)

 

  > 1

9 (22%)

13 (17.1%)

 

 Type

   

  Diabetes mellitus

15 (36.6%)

30 (39.5%)

0.887

  Hypertension

18 (43.9%)

26 (34.2%)

 

  Heart failure

7 (17%)

13 (17.1%)

 

  Neurologic

3 (7.3%)

4 (5.3%)

 

Left ventricular ejection fraction (%)

52.7 ± 4.8

54.9 ± 5.6

0.0318

Maximal Left atrial diameter (mm)

43 ± 3.9

40 ± 4.9

0.001

Systolic blood pressure (mmHg)

133.7 ± 10.7

130.1 ± 13.2

0.132

Diastolic blood pressure (mmHg)

86.4 ± 7

85 ± 7.3

0.314

  1. Data are presented as mean, standard deviation, numbers, and percentages; RAF: Recurrent atrial fibrillation; p < 0.05 indicates a significant difference; p > 0.05 indicates a non-significant difference